Profile
Sector:
HealthcareCountry:
United StatesIPO:
05 May 2000Next earnings report:
08 November 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | 26 min agoDividend
Analysts recommendations
Institutional Ownership
ANIP Latest News
PRINCETON, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at at two upcoming investor conferences as follows:
ANI (ANIP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PRINCETON, N.J., Oct. 30, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its third quarter 2024 financial results on Friday, November 8, 2024, prior to the market open.
PRINCETON, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), the Company launched Estradiol Gel, 0.06%. ANI's Estradiol Gel, 0.06% is the generic version of the reference listed drug (RLD) EstroGel® Gel, 0.06%.
Two poster presentations demonstrate ANI's commitment to research in membranous nephropathy care Two poster presentations demonstrate ANI's commitment to research in membranous nephropathy care
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
ANI (ANIP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Piper Sandler has initiated coverage on ANI Pharmaceuticals ANIP, an integrated specialty pharmaceutical firm that develops and markets branded and generic medicines.
Today, we revisit small biopharma ANI Pharmaceuticals, as it is a GARP stock trading near technical support, with solid growth prospects. The company recently acquired Alimera Sciences for $380 million, boosting its rare disease segment with a couple of durable ophthalmology products. Analyst firms are generally bullish on the company's prospects and the stock trades at 12 times trailing earnings, despite revenue growth in the high teens.
What type of business is ANI Pharmaceuticals?
ANI Pharmaceuticals, Inc. is a pharmaceutical company. Founded in 2001 in the state of Delaware. The headquarters are located in Baudette, Minnesota. The company's main activities include the development, production, and marketing of branded and prescription pharmaceuticals. A wide range of products produced includes medications used to treat various diseases, including cardiovascular, neurological, endocrine, infectious, gastrointestinal, and dermatological diseases, pain relievers, as well as medications for cancer treatment, hormones, and steroids. The company has three manufacturing facilities and its own laboratories that not only control the quality of the raw materials used but also engage in the development of pharmaceuticals.
What sector is ANI Pharmaceuticals in?
ANI Pharmaceuticals is in the Healthcare sector
What industry is ANI Pharmaceuticals in?
ANI Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry
What country is ANI Pharmaceuticals from?
ANI Pharmaceuticals is headquartered in United States
When did ANI Pharmaceuticals go public?
ANI Pharmaceuticals initial public offering (IPO) was on 05 May 2000
What is ANI Pharmaceuticals website?
https://www.anipharmaceuticals.com
Is ANI Pharmaceuticals in the S&P 500?
No, ANI Pharmaceuticals is not included in the S&P 500 index
Is ANI Pharmaceuticals in the NASDAQ 100?
No, ANI Pharmaceuticals is not included in the NASDAQ 100 index
Is ANI Pharmaceuticals in the Dow Jones?
No, ANI Pharmaceuticals is not included in the Dow Jones index
When was ANI Pharmaceuticals the previous earnings report?
No data
When does ANI Pharmaceuticals earnings report?
The next expected earnings date for ANI Pharmaceuticals is 08 November 2024